BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24999676)

  • 1. 123I-ioflupane SPECT findings of pantothenate kinase-associated neurodegeneration.
    Kang A; Minoshima S
    Clin Nucl Med; 2014 Sep; 39(9):849-51. PubMed ID: 24999676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: clinical features and (99m)Tc-ECD brain perfusion SPECT findings.
    Doi H; Koyano S; Miyatake S; Matsumoto N; Kameda T; Tomita A; Miyaji Y; Suzuki Y; Sawaishi Y; Kuroiwa Y
    J Neurol Sci; 2010 Mar; 290(1-2):172-6. PubMed ID: 20006850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
    Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T
    Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pantothenate kinase-associated neurodegeneration with increased lentiform nuclei cerebral blood flow.
    Koyama M; Yagishita A
    AJNR Am J Neuroradiol; 2006 Jan; 27(1):212-3. PubMed ID: 16418386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.
    Hayflick SJ; Westaway SK; Levinson B; Zhou B; Johnson MA; Ching KH; Gitschier J
    N Engl J Med; 2003 Jan; 348(1):33-40. PubMed ID: 12510040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of
    Kotikova K; Zogala D; Ptacnik V; Trnka J; Kupka K; Vaneckova M; Seidl Z; Diblik P; Heissigerova J; Navratil T; Komarc M; Zak I; Polakova K; Brozova H; Zakharov S
    Clin Toxicol (Phila); 2021 Mar; 59(3):235-245. PubMed ID: 32762574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal and pontocerebellar hypoperfusion in Hallervorden-Spatz syndrome.
    Castelnau P; Zilbovicius M; Ribeiro MJ; Hertz-Pannier L; Ogier H; Evrard P
    Pediatr Neurol; 2001 Aug; 25(2):170-4. PubMed ID: 11551749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [123I]FP-CIT SPECT findings in two patients with Hallervorden-Spatz disease with homozygous mutation in PANK2 gene.
    Cossu G; Cella C; Melis M; Antonini A; Floris GL; Ruffini L; Spissu A
    Neurology; 2005 Jan; 64(1):167-8. PubMed ID: 15642932
    [No Abstract]   [Full Text] [Related]  

  • 9. Pantothenate - kinase associated neurodegeneration.
    Parmar A; Khare S; Srivastav V
    J Assoc Physicians India; 2012 Apr; 60():74-6. PubMed ID: 23029753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnetic resonance diagnosis of Hallervorden-Spatz disease].
    Bonetti M; Prandini F; Gasparotti R; Pavia M; Crispino M; Pittiani F
    Radiol Med; 1994 Dec; 88(6):869-70. PubMed ID: 7878250
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of Hallervorden-Spatz syndrome diagnosed antemortemly.
    Thajeb P
    Chin Med J (Engl); 1993 Feb; 106(2):153-6. PubMed ID: 8504699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure akinesia: an unusual phenotype of Hallervorden-Spatz syndrome.
    Molinuevo JL; Martí MJ; Blesa R; Tolosa E
    Mov Disord; 2003 Nov; 18(11):1351-3. PubMed ID: 14639680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
    Tanteles GA; Spanou-Aristidou E; Antoniou C; Christophidou-Anastasiadou V; Kleopa KA
    J Neurol Sci; 2014 May; 340(1-2):233-6. PubMed ID: 24655737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
    Thomas M; Hayflick SJ; Jankovic J
    Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hallervorden-Spatz disease: findings in the nigrostriatal system].
    Hermann W; Barthel H; Reuter M; Georgi P; Dietrich J; Wagner A
    Nervenarzt; 2000 Aug; 71(8):660-5. PubMed ID: 10996917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of Hallervorden-Spatz disease using MRI, (123)I-beta-CIT-SPECT and (123)I-IBZM-SPECT.
    Hermann W; Reuter M; Barthel H; Dietrich J; Georgi P; Wagner A
    Eur Neurol; 2000; 43(3):187-8. PubMed ID: 10765064
    [No Abstract]   [Full Text] [Related]  

  • 17. "Eye of the Tiger" in a Non-Responsive Neuropsychiatric Patient: A Case Report.
    Hosseinialhashemi M; Daneshfard B; Hashemi A
    Acta Med Iran; 2018 Jan; 56(1):71-73. PubMed ID: 29436799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.
    Hayflick SJ; Hartman M; Coryell J; Gitschier J; Rowley H
    AJNR Am J Neuroradiol; 2006; 27(6):1230-3. PubMed ID: 16775270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult Hallervorden-Spatz syndrome simulating amyotrophic lateral sclerosis.
    Vasconcelos OM; Harter DH; Duffy C; McDonough B; Seidman JG; Seidman CE; Campbell WW
    Muscle Nerve; 2003 Jul; 28(1):118-22. PubMed ID: 12811783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations.
    Sethi KD; Adams RJ; Loring DW; el Gammal T
    Ann Neurol; 1988 Nov; 24(5):692-4. PubMed ID: 3202617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.